Alvimopan, a Peripherally Acting μ-Opioid Receptor Antagonist, is Associated with Reduced Costs after Radical Cystectomy: Economic Analysis of a Phase 4 Randomized, Controlled Trial
Keywords: urinary bladder; gastrointestinal tract; ileus; postoperative complications; cost-benefit analysisDRG, diagnosis related group; ECG, electrocardiogram; GI, gastrointestinal; LOS, length of hospital stay; NGT, nasogastric tube; POI, postoperative ileus; RC